Search - tctmd.com

Displaying 41 - 60 of 63

Sort: Relevancy | Date

News Features

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Michael O'Riordan

April 07, 2020

News Daily News

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

Michael O'Riordan

March 17, 2020

News Daily News

ACS After TAVR a Unique Condition With Poor Prognosis

Todd Neale

February 05, 2020

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Conference News EAS 2019

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

Michael O'Riordan

June 07, 2019

News Daily News

SCAI Updates Statement on Intracoronary Diagnostic Tools

Todd Neale

July 17, 2018

News Daily News

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Shelley Wood

April 13, 2018

News Daily News

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

Yael L. Maxwell

March 23, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2017

Shelley Wood

October 29, 2017

News Daily News

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Michael O'Riordan

July 03, 2017

Presentation TVT 2017

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

Presenter: Samir R. Kapadia

June 16, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Conference News ACC 2016

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Yael L. Maxwell

April 06, 2016

News Daily News

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

L.A. McKeown

November 01, 2015

News Industry News

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

October 15, 2015

News Conference News TCT 2015

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Yael L. Maxwell

October 15, 2015

Presentation TCT 2014

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Presenter: Viliam Fridrich, Petr Kala, Josef Stasek, Alec S. Vahanian, Pavel Cervinka

September 14, 2014

Advertisement

‘Salvage What We Can’: Cardiology Clinical Trials in Turmoil Amid COVID-19

Preventing TAVR Obstruction of Coronary Arteries Remains a Challenge

ACS After TAVR a Unique Condition With Poor Prognosis

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Should Lp(a) Be Measured and Treated? Two Experts Hash Out Its Current Role

SCAI Updates Statement on Intracoronary Diagnostic Tools

‘Striking’ Rise in TAVR Among Patients With Previous CABG

Coronary Procedures After TAVR: New Practical Guide Reviews Tools, Techniques

TCTMD’s Top 10 Most Popular Stories for October 2017

More Vascular Complications, Higher 30-Day Mortality With PCI Prior to TAVR: Meta-Analysis

Managing AS Patients With Atrial Fibrillation After TAVR Pharmacotherapy Considerations and LAAC Possibilities

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Choosing Radial Over Femoral: Single-Center Study Tackles Questions of When and Why

Stroke Risk With Carotid Stenting Persists Over Time: Meta-Analysis

Similar Results With Bivalirudin Compared With Heparin Anticoagulation In TAVR Patients

BRAVO 3: Bivalirudin Similar to Heparin in Transfemoral TAVR

Case #1: Complex Patient with NSTEMI and Severe Aortic Stenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content